A new daily pill, orforglipron, significantly aided weight loss in clinical trials involving thousands of adults.
One in five participants lost 20% or more of their body weight after 72 weeks of consistent daily use.
This oral medication offers a more convenient alternative to injectable weight-loss treatments, potentially increasing accessibility.
While not yet FDA-approved, the pill's effectiveness and potential impact on public health are substantial.
